Latest news with #EdwardChung
Yahoo
29-05-2025
- Business
- Yahoo
Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference
HERCULES, Calif., May 29, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Operating Officer Jon DiVincenzo will host one-on-one meetings with investors during the Jefferies Global Healthcare Conference in New York City, on June 4, 2025. About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 7,500 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit View source version on Contacts Investor Contact: Edward Chung, Investor Relations510-741-6104ir@ Media Contact: Anna Gralinska, Corporate Communications510-741-6643cc@ Sign in to access your portfolio
News.com.au
22-05-2025
- Business
- News.com.au
‘One of the quietest success stories': TechnologyOne soars on record half-year profit
TechnologyOne's shares shot the lights out on Tuesday and Wednesday after a half-year profit result that sets it up now for record revenue and profit for the 16th straight year. TechnologyOne Chief Executive Edward Chung claims the company provides 'mission-critical software' for some defined vertical markets.
Sky News AU
21-05-2025
- Business
- Sky News AU
‘One of the quietest success stories': TechnologyOne soars on record half-year profit
TechnologyOne's shares shot the lights out on Tuesday and Wednesday after a half-year profit result that sets it up now for record revenue and profit for the 16th straight year. TechnologyOne Chief Executive Edward Chung claims the company provides 'mission-critical software' for some defined vertical markets. 'We've been around for a long time and probably one of the quietest success stories, as you say, in the Australian market,' he told Sky News Business Editor Ross Greenwood.
Yahoo
15-04-2025
- Business
- Yahoo
Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
HERCULES, Calif., April 15, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2025 on Thursday, May 1, 2025, following the close of the market. Management will discuss these results in a conference call scheduled for 2:30 PM Pacific Time (5:30 PM Eastern Time) that day. To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live webcast of the conference call will also be available in the "Investor Relations" section of the company's website under "Events & Presentations" at A replay of the webcast will be available for up to a year. About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit View source version on Contacts Investor Contact: Edward Chung, Investor Relations510-741-6104ir@ Media Contact: Anna Gralinska, Corporate Communications510-741-6643cc@ Sign in to access your portfolio
Yahoo
27-01-2025
- Business
- Yahoo
Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025
HERCULES, Calif., January 27, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year of 2024 on Thursday, February 13, 2025, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day. To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live webcast of the conference call will also be available in the "Investor Relations" section of the company's website under "Events & Presentations" at A replay of the webcast will be available for up to a year. About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit View source version on Contacts Investor Contact: Edward Chung, Investor Relations510-741-6104ir@ Media Contact: Anna Gralinska, Corporate Communications510-741-6643cc@
